questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Vaccins sous-unitaires
Vaccins acellulaires
Vaccins diphtérique tétanique coquelucheux acellulaires
Vaccins diphtérique tétanique coquelucheux acellulaires : Questions médicales fréquentes
Diagnostic
5
Consultation médicale
Symptômes
Symptômes
5
Symptômes
Éruptions cutanées
Prévention
5
Effets secondaires
Vaccins
Traitements
5
Traitements alternatifs
Consultation médicale
Complications
5
Complications
Soins médicaux
Vaccins
Effets secondaires
Facteurs de risque
5
Diphtérie
Facteurs de risque
Tétanos
Facteurs de risque
Coqueluche
Facteurs de risque
Femmes enceintes
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins diphtérique tétanique coquelucheux acellulaires : Questions médicales les plus fréquentes",
"headline": "Vaccins diphtérique tétanique coquelucheux acellulaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins diphtérique tétanique coquelucheux acellulaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-12",
"dateModified": "2026-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins diphtérique tétanique coquelucheux acellulaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins acellulaires",
"url": "https://questionsmedicales.fr/mesh/D022282",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins acellulaires",
"code": {
"@type": "MedicalCode",
"code": "D022282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.860.900"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vaccins diphtérique tétanique coquelucheux acellulaires",
"alternateName": "Diphtheria-Tetanus-acellular Pertussis Vaccines",
"code": {
"@type": "MedicalCode",
"code": "D022681",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Vitali Pool",
"url": "https://questionsmedicales.fr/author/Vitali%20Pool",
"affiliation": {
"@type": "Organization",
"name": "US Medical, Sanofi, Swiftwater, PA, USA."
}
},
{
"@type": "Person",
"name": "Laura Campora",
"url": "https://questionsmedicales.fr/author/Laura%20Campora",
"affiliation": {
"@type": "Organization",
"name": "GSK, Wavre, Belgium."
}
},
{
"@type": "Person",
"name": "Brigitte Cheuvart",
"url": "https://questionsmedicales.fr/author/Brigitte%20Cheuvart",
"affiliation": {
"@type": "Organization",
"name": "GSK, Wavre, Belgium."
}
},
{
"@type": "Person",
"name": "Susan Hariri",
"url": "https://questionsmedicales.fr/author/Susan%20Hariri",
"affiliation": {
"@type": "Organization",
"name": "Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia."
}
},
{
"@type": "Person",
"name": "Maria Angeles Ceregido",
"url": "https://questionsmedicales.fr/author/Maria%20Angeles%20Ceregido",
"affiliation": {
"@type": "Organization",
"name": "GSK, Wavre, Belgium."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV.",
"datePublished": "2023-10-03",
"url": "https://questionsmedicales.fr/article/37773052",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/QAD.0000000000003731"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in China.",
"datePublished": "2023-10-11",
"url": "https://questionsmedicales.fr/article/37832931",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijid.2023.10.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "A study of acceptance and hesitation factors towards tetanus, diphtheria, and acellular pertussis (Tdap) and influenza vaccines during pregnancy.",
"datePublished": "2023-07-07",
"url": "https://questionsmedicales.fr/article/37519777",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jvacx.2023.100351"
}
},
{
"@type": "ScholarlyArticle",
"name": "Influenza and Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage During Pregnancy: Pregnancy Risk Assessment Monitoring System, 2020.",
"datePublished": "2023-06-29",
"url": "https://questionsmedicales.fr/article/37386826",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00333549231179252"
}
},
{
"@type": "ScholarlyArticle",
"name": "Antibody persistence to diphtheria toxoid, tetanus toxoid,",
"datePublished": "2024-05-16",
"url": "https://questionsmedicales.fr/article/38752802",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2024.2352909"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins sous-unitaires",
"item": "https://questionsmedicales.fr/mesh/D022223"
},
{
"@type": "ListItem",
"position": 6,
"name": "Vaccins acellulaires",
"item": "https://questionsmedicales.fr/mesh/D022282"
},
{
"@type": "ListItem",
"position": 7,
"name": "Vaccins diphtérique tétanique coquelucheux acellulaires",
"item": "https://questionsmedicales.fr/mesh/D022681"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins diphtérique tétanique coquelucheux acellulaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins diphtérique tétanique coquelucheux acellulaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaccins diphtérique tétanique coquelucheux acellulaires",
"description": "Comment diagnostiquer une infection à coqueluche ?\nQuels tests pour la diphtérie ?\nComment évaluer le tétanos ?\nQuels signes indiquent une infection ?\nQuand consulter un médecin ?",
"url": "https://questionsmedicales.fr/mesh/D022681#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins diphtérique tétanique coquelucheux acellulaires",
"description": "Quels sont les symptômes de la diphtérie ?\nQuels signes de la coqueluche ?\nQuels symptômes du tétanos ?\nComment se manifeste la coqueluche chez les bébés ?\nY a-t-il des symptômes atypiques ?",
"url": "https://questionsmedicales.fr/mesh/D022681#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins diphtérique tétanique coquelucheux acellulaires",
"description": "Comment prévenir la diphtérie ?\nQuand vacciner contre le tétanos ?\nComment éviter la coqueluche ?\nLes vaccins sont-ils sûrs ?\nY a-t-il des effets secondaires des vaccins ?",
"url": "https://questionsmedicales.fr/mesh/D022681#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins diphtérique tétanique coquelucheux acellulaires",
"description": "Quel traitement pour la diphtérie ?\nComment traiter le tétanos ?\nQuel est le traitement de la coqueluche ?\nLes vaccins sont-ils un traitement ?\nY a-t-il des traitements alternatifs ?",
"url": "https://questionsmedicales.fr/mesh/D022681#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins diphtérique tétanique coquelucheux acellulaires",
"description": "Quelles complications de la diphtérie ?\nQuels risques liés au tétanos ?\nComplications possibles de la coqueluche ?\nComment gérer les complications ?\nY a-t-il des complications des vaccins ?",
"url": "https://questionsmedicales.fr/mesh/D022681#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins diphtérique tétanique coquelucheux acellulaires",
"description": "Qui est à risque de diphtérie ?\nQuels facteurs augmentent le risque de tétanos ?\nQui est vulnérable à la coqueluche ?\nLes adultes peuvent-ils être à risque ?\nY a-t-il des risques pour les femmes enceintes ?",
"url": "https://questionsmedicales.fr/mesh/D022681#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection à coqueluche ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests PCR ou culture de prélèvements respiratoires."
}
},
{
"@type": "Question",
"name": "Quels tests pour la diphtérie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un prélèvement pharyngé et une culture bactérienne sont nécessaires pour confirmer la diphtérie."
}
},
{
"@type": "Question",
"name": "Comment évaluer le tétanos ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur les antécédents cliniques et l'examen physique, sans test spécifique."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux persistante, raideur musculaire et difficultés respiratoires peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si vous présentez des symptômes de diphtérie, tétanos ou coqueluche."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la diphtérie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent mal de gorge, fièvre, et formation d'une membrane dans la gorge."
}
},
{
"@type": "Question",
"name": "Quels signes de la coqueluche ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Toux paroxystique, vomissements après la toux, et apnées chez les nourrissons sont fréquents."
}
},
{
"@type": "Question",
"name": "Quels symptômes du tétanos ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Raideur musculaire, spasmes, et difficulté à avaler sont des symptômes typiques du tétanos."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la coqueluche chez les bébés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bébés peuvent avoir des épisodes de toux sévère, souvent accompagnés de pauses respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes atypiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes atypiques peuvent inclure des éruptions cutanées ou des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir la diphtérie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination est le moyen le plus efficace de prévenir la diphtérie."
}
},
{
"@type": "Question",
"name": "Quand vacciner contre le tétanos ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le vaccin contre le tétanos est recommandé tous les 10 ans, avec des rappels si nécessaire."
}
},
{
"@type": "Question",
"name": "Comment éviter la coqueluche ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination et l'évitement des contacts avec des personnes infectées sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils sûrs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins diphtérique tétanique coquelucheux acellulaires sont sûrs et efficaces."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des vaccins ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires sont généralement légers, comme une douleur au site d'injection ou de la fièvre."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la diphtérie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'antibiothérapie et l'administration d'antitoxine diphtérique."
}
},
{
"@type": "Question",
"name": "Comment traiter le tétanos ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement nécessite des soins intensifs, des antitoxines et des antibiotiques."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de la coqueluche ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont prescrits, mais le traitement est principalement symptomatique."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils un traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins sont préventifs, mais ils ne traitent pas les infections déjà présentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements alternatifs ne sont pas recommandés; consultez un médecin pour des soins appropriés."
}
},
{
"@type": "Question",
"name": "Quelles complications de la diphtérie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des problèmes respiratoires, cardiaques et neurologiques."
}
},
{
"@type": "Question",
"name": "Quels risques liés au tétanos ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tétanos peut entraîner des spasmes musculaires graves, des fractures et des infections secondaires."
}
},
{
"@type": "Question",
"name": "Complications possibles de la coqueluche ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent pneumonie, convulsions et apnées, surtout chez les nourrissons."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent souvent une hospitalisation et des soins médicaux intensifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications des vaccins ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications graves sont rares; la plupart des effets sont bénins et temporaires."
}
},
{
"@type": "Question",
"name": "Qui est à risque de diphtérie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes non vaccinées ou vivant dans des zones à faible couverture vaccinale sont à risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de tétanos ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les blessures contaminées, l'absence de vaccination et les conditions de vie précaires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Qui est vulnérable à la coqueluche ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nourrissons et les jeunes enfants, surtout ceux non vaccinés, sont les plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les adultes peuvent-ils être à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les adultes peuvent être à risque s'ils n'ont pas reçu de rappels de vaccination."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour les femmes enceintes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes enceintes non vaccinées peuvent transmettre des infections à leur bébé, augmentant le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/04/2026
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
US Medical, Sanofi, Swiftwater, PA, USA.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
5 publications dans cette catégorie
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
5 publications dans cette catégorie
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
5 publications dans cette catégorie
Affiliations :
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
4 publications dans cette catégorie
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
4 publications dans cette catégorie
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
4 publications dans cette catégorie
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
4 publications dans cette catégorie
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
4 publications dans cette catégorie
Affiliations :
Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
4 publications dans cette catégorie
Affiliations :
Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
Maternal Vaccination in Argentina: Tetanus, Diphtheria, and Acellular Pertussis Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants <2 Months of Age.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016-2019.
AJPM focus
2022-12-22
Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination During Pregnancy: Impact on Infant Anti-Pertussis Antibody Concentrations by Maternal Pertussis Priming Series.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
US Infant Pertussis Incidence Trends Before and After Implementation of the Maternal Tetanus, Diphtheria, and Pertussis Vaccine.
JAMA pediatrics
3 publications dans cette catégorie
Affiliations :
Global Medical, Sanofi, Swiftwater, PA, USA.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
3 publications dans cette catégorie
Affiliations :
From the Kaiser Permanente Vaccine Study Center, Oakland, California.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
3 publications dans cette catégorie
Affiliations :
Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. Electronic address: Lina.S.Sy@kp.org.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
3 publications dans cette catégorie
Affiliations :
Dalhousie University, Canadian Center for Vaccinology, Halifax, NS B3K 6R8, Canada.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
3 publications dans cette catégorie
Affiliations :
Centre for the Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
3 publications dans cette catégorie
Affiliations :
Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
2 publications dans cette catégorie
Affiliations :
Global Medical Evidence Generation, Sanofi, Lyon, France.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
2 publications dans cette catégorie
Affiliations :
Odum School of Ecology, University of Georgia, Athens.
Department of Infectious Diseases, University of Georgia, Athens.
Center for the Ecology of Infectious Diseases, University of Georgia, Athens.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
2 publications dans cette catégorie
Affiliations :
Sanofi Pasteur, Swiftwater, Pennsylvania.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
2 publications dans cette catégorie
Affiliations :
Sanofi Pasteur, Swiftwater, Pennsylvania.
Publications dans "Vaccins diphtérique tétanique coquelucheux acellulaires" :
Vaccination during pregnancy with tetanus-diphtheria-acellular pertussis (Tdap) vaccine is recommended to protect the young infants against pertussis. There is a paucity of data on immune responses to...
In an open label phase IV clinical trial in South Africa, we evaluated the immunogenicity and safety of Tdap in PWWH compared with HIV-uninfected women. Antigen-specific immunoglobulin G (IgG) to pert...
Overall, 91 PWWH and 136 HIV-uninfected pregnant women were enrolled. All PWWH were on antiretroviral treatment and 94.5% had HIV viral loads <40 copies per millilitre. Antibody levels prevaccination ...
Tdap vaccination was safe and immunogenic. PWHW had, however, attenuated humoral immune responses, which could affect the effectiveness of protecting their infants against pertussis compared with thos...
During the COVID-19 pandemic, there was a decline in vaccine coverage, and the implementation of combined vaccines and co-administration strategies emerged as potential solutions to alleviate this pre...
This study was a follow-up trial of the "Immunogenicity and safety of concomitant administration of the sIPV with the DTaP vaccine in children: a multicenter, randomized, non-inferiority, controlled t...
The geometric mean titer of the poliovirus types I, II, and III neutralizing antibodies were 1060.22 (95% CI: 865.73-1298.39), 1537.06 (95% CI: 1324.27-1784.05), and 1539.10 (95% CI: 1296.37-1827.29) ...
Co-administration of the sIPV, DTaP, and MMR was safe and did not impact immunogenicity, which would help to mitigate administrative costs and enhance vaccine coverage rates....
Vaccination of pregnant women with tetanus, diphtheria, and acellular pertussis (Tdap) and influenza vaccines is desirable to reduce neonatal and maternal morbidity and mortality. However, vaccine cov...
To ascertain Tdap and influenza vaccine coverage rates in our population and to study the reasons behind sub-optimal rates....
A survey was submitted to pregnant or in their puerperium women at the University Hospital of São Paulo University. Data were obtained during two consecutive influenza seasons (2017-2018), and vaccina...
In a studied sample of 207 patients (representative of the whole), coverage rates for Tdap and influenza vaccines were respectively 85.5% and 95.2%. Additionally, 84.5% received both vaccines. There w...
While influenza vaccination coverage during pregnancy was ideal, Tdap rates were below recommended values. Significant factors associated with better coverage for Tdap during pregnancy included being ...
Estimates of vaccination coverage during pregnancy and identification of disparities in vaccination coverage can inform vaccination campaigns and programs. We reported the prevalence of being offered ...
We analyzed 2020 data from the Pregnancy Risk Assessment Monitoring System from 42 US jurisdictions (n = 41 673). We estimated the overall prevalence of being offered or told to get the influenza vacc...
In 2020, 84.9% of women reported being offered or told to get the influenza vaccine, and 60.9% received it, ranging from 35.0% in Puerto Rico to 79.7% in Massachusetts. Influenza vaccination coverage ...
These results can inform vaccination programs and strategies to address disparities in vaccination coverage during pregnancy and may inform vaccination efforts for other infectious diseases among preg...
Thailand has incorporated the whole-cell (wP) pertussis vaccine into the expanded program on immunization since 1977 and has offered the acellular pertussis (aP) vaccine as an optional vaccine for inf...
Luminex bead-based assays offer multiplexing to test antibodies against multiple antigens simultaneously; however, this requires validation using internationally certified reference standards. Therefo...
The MIA was assessed using a panel of human serum samples and WHO reference standards. The WHO reference standards were also studied for suitability in the MIA. Purified antigens (PT, FHA, PRN, DT, an...
We identified that an equimix of WHO international standards (i.e., 06/142, 10/262, and TE-3) afforded the best dynamic range for all the antigens in the MIA. For all five antigens, we observed that t...
The MIA that was calibrated in accordance with WHO reference standards demonstrated increased sensitivity, reproducibility, and high throughput capabilities, allowing for the design of robust studies ...
Despite high pediatric vaccination coverage rates (VCRs), pertussis incidence has increased worldwide, including in several countries in Latin America in the last two decades. Given the few vaccine ef...
A 20-month-old girl was diagnosed with Guillain - Barré syndrome (GBS) based on progressive muscle weakness, areflexia, and albuminocytologic dissociation of the cerebrospinal fluid. Despite timely an...
Tdap is an acronym for tetanus(T), diphtheria(D), and acellular pertussis(aP), and is a preventive vaccine that combines vaccines against three diseases. BVN008 is a Tdap vaccine designed to protect a...
Infant vaccination coverage rates in Peru have declined in recent years, exacerbated by the COVID-19 pandemic. Introduction of the fully-liquid diphtheria, tetanus, and acellular pertussis (DTaP)-inac...
The analysis was performed over a 5-year period on a cohort of children born in Peru in 2020 (N = 494,595). Four scenarios were considered: the pentavalent plus IPV/OPV scheme (S1); replacing the pent...
The overall cost from a public health payer perspective associated with the pentavalent plus IPV/OPV vaccine scheme (S1) was estimated at $56,719,350, increasing to $61,324,263 (+ 8.1%), $59,121,545 (...
Implementation of the hexavalent vaccine in Peru's National Immunization Program has a positive public health cost consequence....